In the last trading session, 3.69 million Helius Medical Technologies Inc (NASDAQ:HSDT) shares changed hands as the company’s beta touched 1.42. With the company’s per share price at $0.96 changed hands at $0.05 or 5.49% during last session, the market valuation stood at $6.78M. HSDT’s last price was a discount, traded about -889.58% off its 52-week high of $9.50. The share price had its 52-week low at $0.37, which suggests the last value was 61.46% up since then. When we look at Helius Medical Technologies Inc’s average trading volume, we note the 10-day average is 12.29 million shares, with the 3-month average coming to 2.26 million.
Analysts gave the Helius Medical Technologies Inc (HSDT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HSDT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Helius Medical Technologies Inc’s EPS for the current quarter is expected to be -0.94.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Instantly HSDT was in green as seen at the end of in last trading. With action 100.04%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -88.06%, with the 5-day performance at 100.04% in the green. However, in the 30-day time frame, Helius Medical Technologies Inc (NASDAQ:HSDT) is 123.15% up. Looking at the short shares, we see there were 0.23 million shares sold at short interest cover period of 0.34 days.
Helius Medical Technologies Inc (HSDT) estimates and forecasts
Year-over-year growth is forecast to reach -27.33% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 100k. 1 analysts are of the opinion that Helius Medical Technologies Inc’s revenue for the current quarter will be 100k. The company’s revenue for the corresponding quarters a year ago was 134k and 135k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -25.37%. The estimates for the next quarter sales put growth at -25.93%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 63.34%. The 2024 estimates are for Helius Medical Technologies Inc earnings to increase by 61.26%.
HSDT Dividends
Helius Medical Technologies Inc is expected to release its next quarterly earnings report in January.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.53% of Helius Medical Technologies Inc shares while 5.87% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.90%.
